Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages.
Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages.
复制标题
DOI:
10.1016/j.coi.2009.09.004
复制
发表时间:
2009-10
影响因子:
7
通讯作者:
Suzuki T
中科院分区:
文献类型:
--
作者:
Trapnell BC;Carey BC;Uchida K;Suzuki T
Pulmonary alveolar proteinosis (PAP) is a rare syndrome characterized by accumulation of pulmonary surfactant, respiratory insufficiency, and increased infections. It occurs in various clinical settings that disrupt surfactant catabolism in alveolar macrophages, including a relatively more common autoimmune disease caused by GM-CSF autoantibodies and a rare congenital disease caused by CSF2RA mutations. Recent results demonstrate that GM-CSF is critical for alveolar macrophage terminal differentiation and immune functions, pulmonary surfactant homeostasis, and lung host defense. GM-CSF is also required for the basal functional capacity of circulating neutrophils, including adhesion, phagocytosis, and microbial killing. PAP research has illuminated the critical role of GM-CSF in innate immunity and led to novel therapy for PAP and the potential use of anti-GM-CSF therapy in other common disorders.
登录
查看更多内容
DOI:
10.1084/jem.20080759
发表时间:
2008-11-24
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Martinez-Moczygemba M;Doan ML;Elidemir O;Fan LL;Cheung SW;Lei JT;Moore JP;Tavana G;Lewis LR;Zhu Y;Muzny DM;Gibbs RA;Huston DP
通讯作者:
Huston DP
影响因子:
13.6
作者:
Kitching, AR;Huang, XR;Holdsworth, SR
通讯作者:
Holdsworth, SR
DOI:
10.1152/ajplung.00275.2003
发表时间:
2004-04-01
影响因子:
4.9
作者:
Bozinovski, S;Jones, J;Anderson, GP
通讯作者:
Anderson, GP
DOI:
10.1152/ajplung.00216.2003
发表时间:
2003-11-01
影响因子:
4.9
作者:
Bonfield, TL;Raychaudhuri, B;Thomassen, MJ
通讯作者:
Thomassen, MJ
DOI:
10.1152/ajplung.00413.2001
发表时间:
2002-09-01
影响因子:
4.9
作者:
Frossard, JL;Saluja, AK;Steer, ML
通讯作者:
Steer, ML